Sanofi (France), Emcure Pharmaceuticals Limited Ink Marketing Pact For Cancer Drugs

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sanofi India Ltd. announced that it has entered into a marketing and distribution agreement with Emcure Pharmaceuticals for its oncology portfolio in India.

Under the agreement terms, while Sanofi will continue to own its oncology range, comprising 4 brands namely Taxotere, Jevtana, Fludara and Fasturtec, Emcure will market and distribute these brands through its Specialty Unit.

Commenting on the partnership, Shailesh Ayyangar, Vice President -South Asia and Managing Director -Sanofi India and Sanofi -Synthelabo (India) Ltd. said, "Sanofi is highly committed to the field of Oncology.

Help employers find you! Check out all the jobs and post your resume.

Back to news